Warberg Asset Management’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Warberg Asset Management’s Portfolio GMVD Stock Details GMVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-33,000	Closed	-$12.6K	–	296
2023 Q2	$12.6K	Buy	33,000 +8,000	+32%	+$3.6K	﹤0.01%	175
2023 Q1	$22.8K	Buy	+25,000	New	+$71.7K	﹤0.01%	165

Other funds holding GMVD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Warberg Asset Management's GMVD Position: Q3 2023 in Review

Warberg Asset Management sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q3 2023, closing a stake of 33,000 shares — an estimated $12.6K sold.

Warberg Asset Management first reported a position in GMVD in Q1 2023 and held it in 2 quarters. The position peaked at $22.8K in Q1 2023. 3 funds tracked by Wall St. Rank hold GMVD as of Q3 2023.

Warberg Asset Management reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Warberg Asset Management sold 33,000 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q3 2023, an estimated $12.6K.
Warberg Asset Management first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q1 2023 and held it in 2 quarters.
Warberg Asset Management's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $22.8K in Q1 2023.
3 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q3 2023.

Based on Warberg Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.